Urinary Leukotriene E4 as a Biomarker in NSAID-Exacerbated Respiratory Disease (N-ERD): a Systematic Review and Meta-analysis

White AA, Stevenson DD. Aspirin-exacerbated respiratory disease. N Engl J Med. 2018;379:1060–70.

CAS  PubMed  Google Scholar 

•• Kowalski ML, Agache I, Bavbek S, Bakirtas A, Blanca M, Bochenek G, et al. Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)-a EAACI position paper. Allergy. 2019;74:28–39. Position paper summarising current knowledge on the pathophysiology of N-ERD, existing diagnostic tools, and future directions for research.

• Wangberg H, White AA. Aspirin-exacerbated respiratory disease. Curr Opin Immunol. 2020;66:9–13. Review detailing current understanding of the immunopathogenesis of N-ERD.

Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol. 2015;135:676-681.e1.

CAS  PubMed  Google Scholar 

Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ. 2004;328:434.

CAS  PubMed  PubMed Central  Google Scholar 

Laidlaw TM. Clinical updates in aspirin-exacerbated respiratory disease. Allergy Asthma Proc. 2019;40:4–6.

PubMed  PubMed Central  Google Scholar 

Miller B, Mirakian R, Gane S, Larco J, Sannah AA, Darby Y, et al. Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease: asthma and rhinitis. Clin Exp Allergy. 2013;43:874–80.

CAS  PubMed  PubMed Central  Google Scholar 

Bochenek G, Stachura T, Plutecka H, Sanak M, Nizankowska-Mogilnicka E, Sladek K, et al. Diagnostic accuracy of urinary LTE4 measurement to predict aspirin-exacerbated respiratory disease in patients with asthma. J Allerg Clin Immunol: In Practice. Ame Acad Allerg Asthma Immun. 2018;6:528–35.

Comhair SAA, Bochenek G, Baicker-McKee S, Wang Z, Stachura T, Sanak M, et al. The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease. Respir Res. 2018;19:210.

CAS  PubMed  PubMed Central  Google Scholar 

Hagan JB, Laidlaw TM, Divekar R, O’Brien EK, Kita H, Volcheck GW, et al. Urinary leukotriene E4 to determine aspirin intolerance in asthma: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2017;5:990–990.

PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.

PubMed  PubMed Central  Google Scholar 

Drevon D, Fursa SR, Malcolm AL. Intercoder reliability and validity of WebPlotDigitizer in extracting graphed data. Behav Modif. 2017;41:323–39.

PubMed  Google Scholar 

Reitsma JB, Rutjes A, Whiting P, Vlassov V, Leeflang M, Deeks J. Chapter 9: Assessing methodological quality. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. 2009.

Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.

PubMed  PubMed Central  Google Scholar 

Higgins J, Abe S. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collab. 2011. Available from: https://www.handbook.cochrane.org.

Sanak M, Bochenek G, Faber J, Plutecka H, Szczeklik A. Elevated urinary leukotriene E excretion in asthma: a comparison of HPLC-mass spectrometry and ELISA. Allergy. 2010;65:663–4.

CAS  PubMed  Google Scholar 

Higashi N, Taniguchi M, Mita H, Osame M, Akiyama K. A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma. Clinical and experimental allergy : J Br Soc Allerg Clin Immunol. 2002;32:1484–90.

CAS  Google Scholar 

Higashi N, Taniguchi M, Mita H, Ishii T, Akiyama K. Nasal blockage and urinary leukotriene E4 concentration in patients with seasonal allergic rhinitis. Allergy. 2003;58:476–80.

CAS  PubMed  Google Scholar 

Kawagishi Y, Mita H, Taniguchi M, Maruyama M, Oosaki R, Higashi N, et al. Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. J Allergy Clin Immunol. 2002;109:936–42.

CAS  PubMed  Google Scholar 

Mita H, Endoh S, Kudoh M, Kawagishi Y, Kobayashi M, Taniguchi M, et al. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. Allergy. 2001;56:1061–7.

CAS  PubMed  Google Scholar 

Mitsui C, Kajiwara K, Hayashi H, Kinoshita A, Fukutomi Y, Sekiya K, et al. Platelet activation markers overexpressed specifically in aspirinexacerbated respiratory disease. Allergy: European J Allerg Clin Immun. 2015;70:636–636.

Oosaki R, Mizushima Y, Kawasaki A, Kashii T, Mita H, Shida T, et al. Urinary excretion of leukotriene E4 and 11-dehydrothromboxane B2 in patients with spontaneous asthma attacks. Int Arch Allergy Immunol. 1997;114:373–8.

CAS  PubMed  Google Scholar 

Yamaguchi H, Higashi N, Mita H, Ono E, Komase Y, Nakagawa T, et al. Urinary concentrations of 15-epimer of lipoxin A(4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma. Clinical and experimental allergy : J Br Soc Allerg Clin Immunol. 2011;41:1711–8.

CAS  Google Scholar 

Yamaguchi, Ishii T, Yamamoto K, Higashi N, Taniguchi M, Okamoto M. Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma. Auris Nasus Larynx. 2016;43:304–8.

Bochenek G, Nagraba K, Nizankowska E, Szczeklik A. A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. J Allergy Clin Immunol. 2003;111:743–9.

CAS  PubMed  Google Scholar 

Bochenek G, Stachura T, Plutecka H, Sanak M, Nizankowska-Mogilnicka E, Sladek K, et al. Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma. J Allerg Clin Immunol: In Practice. 2018;6:528–35.

Gaber F, Daham K, Higashi A, Higashi N, Gülich A, Delin I, et al. Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma. Thorax. 2008;63:1076–82.

CAS  PubMed  Google Scholar 

Higashi N, Mita H, Ono E, Fukutomi Y, Yamaguchi H, Kajiwara K, et al. Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers. J Allergy Clin Immunol. 2010;125:1084–1084.

CAS  PubMed  Google Scholar 

Jerschow E, Ren Z, Hudes G, Sanak M, Morales E, Schuster V, et al. Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2016;116:321–321.

CAS  Google Scholar 

Mastalerz L, Sanak M, Szczeklik A. Serum interleukin-5 in aspirin-induced asthma. Clinical and experimental allergy : J Br Soc Allerg Clin Immunol. 2001;31:1036–40.

CAS  Google Scholar 

Mastalerz L, Gawlewicz-Mroczka A, Nizankowska E, Cmiel A, Szczeklik A. Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma. Clinical and experimental allergy : J Br Soc Allerg Clin Immunol. 2002a;32:1360–5.

CAS  Google Scholar 

Mastalerz L, Sanak M, Gawlewicz-Mroczka A, Gielicz A, Szczeklik A, Cmiel A. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. Thorax. 2008;63:27–34.

CAS  PubMed  Google Scholar 

Mastalerz L, Januszek R, Kaszuba M, Wójcik K, Celejewska-Wójcik N, Gielicz A, et al. Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics. Prostaglandins Other Lipid Mediat. 2015;121:163–9.

CAS  PubMed  Google Scholar 

Micheletto C, Tognella S, Visconti M, Trevisan F, Dal Negro RW. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics. Respir Med. 2006;100:2144–50.

PubMed  Google Scholar 

Mita H, Higashi N, Taniguchi M, Higashi A, Akiyama K. Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge. Clinical and experimental allergy : J Br Soc Allerg Clin Immunol. 2004;34:1262–9.

CAS  Google Scholar 

Ono E, Taniguchi M, Higashi N, Mita H, Yamaguchi H, Tatsuno S, et al. Increase in salivary cysteinyl-leukotriene concentration in patients with aspirin-intolerant asthma. Allergology international : official journal of the Japanese Society of Allergology. 2011;60:37–43.

CAS  Google Scholar 

Pezato R, Świerczyńska-Krępa M, Niżankowska-Mogilnicka E, Holtappels G, De Ruyck N, Sanak M, et al. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease. Cytokine. 2016;77:157–67.

CAS  PubMed  Google Scholar 

Sanak M, Kiełbasa B, Bochenek G, Szczeklik A. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients. Clinical and experimental allergy: J Br Soc Allerg Clin Immunol. 2004;34:1899–904.

CAS  Google Scholar 

Ban GY, S.-H. K, Yoon MG, Kim JH, Shin YS, Ye YM, et al. Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease. World Allerg Org J. 2016;9:21–21.

Świerczyńska-Krępa M, Sanak M, Bochenek G, Stręk P, Ćmiel A, Gielicz A, et al. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study. J Allergy Clin Immunol. 2014;134:883–90.

PubMed  Google Scholar 

Cahill KN, Bensko JC, Boyce JA, Laidlaw TM. Prostaglandin D2: a dominant mediator of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015;135:245–52.

CAS  PubMed  Google Scholar 

Cahill KN, Cui J, Kothari P, Murphy K, Raby BA, Singer J, et al. Unique effect of aspirin therapy on biomarkers in aspirin-exacerbated respiratory disease. A Prospective Trial. Am J Respir Crit Care Med. 2019;200:704–11.

Laidlaw TM, Kidder MS, Bhattacharyya N, Boyce JA, Milne GL. Increased platelet adherence to leukocytes results in cysteinyl leukotriene (cysLT) overproduction in aspirin exacerbated respiratory disease (AERD). J Allerg Clin Immuno. 2012;129. Available from: https://go.openathens.net/redirector/nhs?url=https%3A%2F%2Fwww.clinicalkey.com%2Fcontent%2FplayBy%2Fdoi%2F%3Fv%3D10.1016%2Fj.jaci.2011.12.455.

Christie PE, Tagari P, Ford-Hutchinson AW, Charlesson S, Chee P, Arm JP, et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis. 1991;143:1025–9.

CAS  PubMed  Google Scholar 

Kumlin M, Dahlén B, Björck T, Zetterström O, Granström E, Dahlén SE. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. Am Rev Respir Dis. 1992;146:96–103.

CAS  PubMed  Google Scholar 

Obase Y, Shimoda T, S.-Y. T, Mitsuta K, Fukushima C, Kawano T, et al. Effects of pranlukast on aspirin-induced bronchoconstriction: differences in chemical mediators between aspirin-intolerant and tolerant asthmatic patients. Annals of Allergy, Asthma and Immunology. 2001;87:74–9.

Obase Y, Shimoda T, Tomari S, Mitsuta K, Kawano T, Matsuse H, et al. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. Chest. 2002;121:143–50.

CAS  PubMed  Google Scholar 

Mastalerz L, Nizankowska E, Sanak M, Mejza F, Pierzchalska M, Bazan-Socha S, et al. Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist. Eur J Clin Invest. 2002b;32:949–55.

CAS  PubMed  Google Scholar 

• Ban G-Y, Kim S-H, Park H-S. Persistent eosinophilic inflammation in adult asthmatics with high serum and urine levels of leukotriene E4. J Asthma Allerg. 2021;14:1219–30. Urinary leukotriene E4 remains significantly higher in N-ERD than aspirin-tolerant asthmatics despite leukotriene receptor antagonist treatment.

• Choi Y., Sim S., Lee D.-H., Shin Y.S., Park H.-S., Lee H.-R., et al. Effect of TGF-beta1 on eosinophils to induce cysteinyl leukotriene E4 production in aspirin-exacerbated respiratory disease. PLoS ONE. Pub Lib Sci. 2021;16. Higher levels of TGF-β1 in N-ERD patients may contribute to urinary leukotriene E4 production via enhancing LTC4S expression which induces eosinophil degranulation, accelerating airway inflammation.

Daffern PJ, Muilenburg D, Hugli TE, Stevenson DD. Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol. 1999;104:559–64.

CAS  PubMed  Google Scholar 

Swierczynska M, Nizankowska-Mogilnicka E, Zarychta J, Gielicz A, Szczeklik A. Nasal versus bronchial and nasal response to oral aspirin challenge: clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis. J Allergy Clin Immunol. 2003;112:995–1001.

CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif